I forgot to mention that I bought shares @ $1.15.
Obesity drug AOD9604:
Patients will be enrolled for the all important Phase IIb trial to start in October and spread over four hospitals.
Duration: three months only. Just about every man and his dog has applied for enrolment so there shouldn't be any hold-ups.
This drug could be of great importance.
Gerry